FindTrial
Sign In

Study on use of Homoeopathy Medicines in Treatment of Covid 19 cases

Homoeopathy Medicines as add-on Therapy in the Management of Covid-19 cases at Covid care centre in kanniyakumari District- A Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/10/028233
Enrollment
60
Registered
2020-10-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: Homoeopathy medicines Arsenicum Album, Bryonia alba, Rhus Toxicodendron, Belladonna Gelsemium and Eupatorium Perfoliatum: Based on individualization Initial prescription starting with 3

Sponsors

Ministry of Ayush
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Covid positive cases who are willing to participate with asymptomatic and mild symptom presentation

Exclusion criteria

Exclusion criteria: patients who are unwilling to participate Moderate to severe disease presentation immuno compromised uncontrolled chronic diseases malignancy

Design outcomes

Primary

MeasureTime frame
1)Incidence of Patients progression from No/Mild symptoms to Moderate/Severe Symptoms 2) Duration from Positive to Negative Timepoint: 1)from baseline until the duration of disease course 2) whole positivity period—

Secondary

MeasureTime frame
frequency of appearance and resolution of symptomsTimepoint: During the whole course of illness—

Countries

India

Contacts

Public ContactDr SUGATHAN N V

sarada krishna homoepathic medical college

college@skhmc.org9443558786

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026